North Star Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-943
| Closed | -$219K | – | 325 |
|
|
2024
Q2 | $219K | Hold |
943
| – | – | 0.01% | 286 |
|
|
2024
Q1 | $203K | Buy |
943
+30
| +3% | +$7.03K | 0.01% | 302 |
|
|
2023
Q4 | $236K | Hold |
913
| – | – | 0.01% | 271 |
|
|
2023
Q3 | $235K | Sell |
913
-7
| -0.8% | -$1.87K | 0.01% | 266 |
|
|
2023
Q2 | $262K | Sell |
920
-55
| -6% | -$16.4K | 0.01% | 258 |
|
|
2023
Q1 | $271K | Sell |
975
-36
| -4% | -$9.96K | 0.02% | 257 |
|
|
2022
Q4 | $280K | Sell |
1,011
-21
| -2% | -$5.93K | 0.02% | 254 |
|
|
2022
Q3 | $275K | Hold |
1,032
| – | – | 0.02% | 246 |
|
|
2022
Q2 | $210K | Buy |
1,032
+10
| +1% | +$2.04K | 0.01% | 270 |
|
|
2022
Q1 | $215K | Hold |
1,022
| – | – | 0.01% | 289 |
|
|
2021
Q4 | $245K | Hold |
1,022
| – | – | 0.01% | 278 |
|
|
2021
Q3 | $289K | Sell |
1,022
-50
| -5% | -$16.4K | 0.02% | 252 |
|
|
2021
Q2 | $371K | Sell |
1,072
-225
| -17% | -$68.2K | 0.02% | 232 |
|
|
2021
Q1 | $363K | Hold |
1,297
| – | – | 0.02% | 219 |
|
|
2020
Q4 | $318K | Sell |
1,297
-200
| -13% | -$51.6K | 0.02% | 227 |
|
|
2020
Q3 | $425K | Hold |
1,497
| – | – | 0.03% | 192 |
|
|
2020
Q2 | $400K | Hold |
1,497
| – | – | 0.03% | 195 |
|
|
2020
Q1 | $473K | Sell |
1,497
-350
| -19% | -$106K | 0.05% | 178 |
|
|
2019
Q4 | $549K | Hold |
1,847
| – | – | 0.04% | 194 |
|
|
2019
Q3 | $430K | Hold |
1,847
| – | – | 0.03% | 204 |
|
|
2019
Q2 | $432K | Sell |
1,847
-50
| -3% | -$11.5K | 0.03% | 207 |
|
|
2019
Q1 | $448K | Hold |
1,897
| – | – | 0.04% | 203 |
|
|
2018
Q4 | $571K | Hold |
1,897
| – | – | 0.05% | 179 |
|
|
2018
Q3 | $670K | Hold |
1,897
| – | – | 0.05% | 181 |
|
|
2018
Q2 | $551K | Sell |
1,897
-560
| -23% | -$157K | 0.05% | 197 |
|
|
2018
Q1 | $673K | Sell |
2,457
-180
| -7% | -$55.9K | 0.06% | 171 |
|
|
2017
Q4 | $840K | Buy |
2,637
+1,969
| +295% | +$632K | 0.08% | 157 |
|
|
2017
Q3 | $209K | Buy |
+668
| New | +$198K | 0.02% | 243 |
|
|
2016
Q4 | – | Sell |
-662
| Closed | -$207K | – | 242 |
|
|
2016
Q3 | $207K | Buy |
+662
| New | +$196K | 0.02% | 226 |
|
|
2016
Q1 | – | Sell |
-691
| Closed | -$212K | – | 244 |
|
|
2015
Q4 | $212K | Hold |
691
| – | – | 0.03% | 224 |
|
|
2015
Q3 | $202K | Hold |
691
| – | – | 0.03% | 225 |
|
|
2015
Q2 | $280K | Hold |
691
| – | – | 0.03% | 218 |
|
|
2015
Q1 | $291K | Hold |
691
| – | – | 0.03% | 205 |
|
|
2014
Q4 | $235K | Hold |
691
| – | – | 0.03% | 224 |
|
|
2014
Q3 | $229K | Hold |
691
| – | – | 0.03% | 225 |
|
|
2014
Q2 | $218K | Hold |
691
| – | – | 0.03% | 232 |
|
|
2014
Q1 | $211K | Buy |
+691
| New | +$219K | 0.03% | 232 |
|
Other funds holding BIIB
North Star Asset Management's BIIB Position: Q3 2024 in Review
North Star Asset Management sold out of Biogen (BIIB) in Q3 2024, closing a stake of 943 shares — an estimated $219K sold.
North Star Asset Management first reported a position in BIIB in Q1 2014 and held it in 37 quarters. The position peaked at $840K in Q4 2017. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.
- North Star Asset Management reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
- North Star Asset Management sold 943 Biogen shares in Q3 2024, an estimated $219K.
- North Star Asset Management first reported a position in Biogen in Q1 2014 and held it in 37 quarters.
- North Star Asset Management's Biogen position peaked at $840K in Q4 2017.
- 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.
Based on North Star Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.